Image-guided core breast biopsy: A suitable method for pre-operative biological characterization of small (pT1) breast carcinomas

Cancer Letters

Volumn 133, Issue 2, 1998, Pages 223-229

  Puglisi, Fabio ^a   Scalone, Simona ^a   Bazzocchi, Massimo ^b   Fabris, Carlo ^b   Cacitti, Veronica ^b   Beltrami, Carlo Alberto ^b   Di Loreto, Carla ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Immunohistochemistry; Large core breast biopsy; Prognosis; pT1 breast carcinoma

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TECHNIQUE; TISSUE NECROSIS;

AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032447110     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00264-X     Document Type: Article

References (37)

1. Joensuu H., Toikkaen S. Prognosis of breast cancer with small primary tumor (pT1). Acta Oncol. 30:1991;793-796.
2. Rosen P.P., Groshen S., Saigo P.E., Kinne D.W., Hellman S. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J. Clin. Oncol. 7:1989;1239-1251.
3. Rosen P.R., Groshen S., Saigo P.E., Kinne D.W., Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J. Clin. Oncol. 7:1989;355-366.
4. Fisher B., Redmond C., Wickerham L., et al. Systemic therapy in patients with node-negative breast cancer. Ann. Intern. Med. 111:1989;703-712.
5. Hunt C.M., Ellis I.O., Elston C.W., Locker A., Pearson D., Blamey R.W. Cytological grading of breast carcinoma-a feasible proposition?, Cytopathology. 1:1990;287-295.
6. Robinson I.A., McKee G., Nicholson A., et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet. 343:1994;947-949.
7. Kung I.T.M., Chan S.K., Lo E.S.F. Application of the immunoperoxidase technique to cell block preparations from fine-needle aspirates. Acta Cytol. 34:1990;297-303.
8. Pinder S.E., Wencyk P.M., Naylor H.E., et al. The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: methods, preliminary results and prognostic associations. Cytopathology. 6:1995;316-324.
9. Troncone G., Zeppa P., Vetrani A., et al. Bcl-2 protein in breast cancer cells obtained by fine needle aspiration (FNA): a prelimirary report. Cytopathology. 6:1995;219-225.
10. Dowell S.P., Lane D.P., Hall P.A. The immunocytochemical detection of p53 protein in cytological specimens: technical considerations. Cytopathology. 5:1994;76-81.
11. Parker S.H., Lovin J.D., Jobe W.E., et al. Stereotactic breast biopsy with a biopsy gun. Radiology. 176:1990;741-747.
12. Parker S.H., Lovin J.D., Jobe W.E., Burke B.J., Hopper K.D., Yakes W.F. Non palpable breast lesions: stereotactic automated large-core biopsies. Radiology. 180:1991;403-407.
13. Parker S.H., Jobe W.E., Dennis M.A., et al. US-guided automated large-core breast biopsy. Radiology. 187:1993;507-511.
14. Parker S.H. Percutaneous large core breast biopsy. Cancer. 74:1994;256-262.
15. Sullivan D.C. Needle core biopsy of mammographic lesions. Am. J. Roentgenol. 162:1994;601-608.
16. Di Loreto C., Puglisi F., Rimondi G., et al. Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. Eur. J. Cancer. 32A:1996;1693-1700.
17. Dahlstrom J.E., Sutton S., Jain S. Histological precision of stereotactic core biopsy in the diagnosis of malignant and premalignant breast lesions. Histopathology. 28:1996;537-541.
18. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 19:1991;403-410.
19. Negri S., Bonetti F., Capitanio A., Bonzanini M. Preoperative diagnostic accuracy of fine-needle aspiration in the management of breast lesions: comparison of specificity and sensitivity with clinical examination, mammography, echography and thermography in 249 patients. Diagn. Cytopathol. 11:1994;4-8.
20. Pinder S.E., Elston C.W., Ellis I.O. The role of pre-operative diagnosis in breast cancer. Histopathology. 28:1996;563-566.
21. Page D.L. Prognosis and breast cancer. Recognition of lethal and favorable prognostic types. Am. J. Surg. Pathol. 15:1991;334-349.
22. Pinder S.E., Ellis I.O., Elston C.W. Prognostic factors in primary breast carcinoma. J. Clin. Pathol. 48:1995;981-983.
23. Clark, G.M., Prognostic and predictive factors, in: J.R. Harris, M.E. Lippman, M. Morrow, S. Helman (Eds.), Diseases of the breast, Lippincott-Raven, Philadelphia, PA, 1996, pp. 461-485.
24. Carter C.L., Allen C., Henson D.E. Relation of tumour size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 63:1989;181-187.
25. Koscielny S., Tubiana M., Le M.G., et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br. J. Cancer. 49:1984;709-715.
26. Fisher B., Bauer M., Wickerham D.L., et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: a NSABP update. Cancer. 52:1983;1551-1557.
27. Saez R.A., McGuire W.L., Clark G.M. Prognostic factors in breast cancer. Semin. Surg. Oncol. 5:1989;102-110.
28. Rosen P.P., Saigo P.E., Braun D.W., Weathers E., DePalo A. Predictors of recurrence in stage 1 (T1N0M0) breast carcinoma. Ann. Surg. 193:1991;15-25.
29. Pinder S.E., Ellis I.O., Galea M.H., O'Rouke S., Blamey R.W., Elston C.W. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large series with long term follow-up. Histopathology. 24:1994;41-47.
30. Silverstein M.J., Gierson E.D., Waisman J.R., Senofsky G.M., Colburn W.J., Gamagami P. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer. 73:1994;664-667.
31. Chadha M., Chabon A.B., Friedmann P., Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer: a multivariate analysis. Cancer. 73:1994;350-353.
32. Ravdin P.M., De Laurentiis M., Vendely T., Clark G.M. Prediction of the axillary nodal status in breast cancer patients by using of prognostic indicators. J. Natl. Cancer Inst. 86:1994;1771-1775.
33. Barth A., Craig P.H., Silverstein M.J. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 79:1997;1918-1922.
34. Fisher E.R., Palekar A.S., Gregorio R.M., Redmond C., Fisher B. Pathological findings from the National Surgical Adjuvant Project for Breast Cancer (protocol 4). IV. Significance of tumour necrosis. Human Pathol. 9:1978;523-530.
35. Sheck L.L.M., Godolphin W. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor combination and tumour necrosis. Cancer Res. 48:1988;5565-5569.
36. Eskelinen M., Lipponen P., Aaltomaa S., Kosma V.M., Syrjanen K., Alhava E. Breast cancer in young women: clinical, histopathological and morphometric prognostic factors. Anticancer Res. 12:1992;1237-1242.
37. Carlomagno C., Perrone F., Lauria R., et al. Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology. 52:1995;272-277.